Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Melissa Eastgate
Prior Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer. Results From a Large International Registry
Clinical Colorectal Cancer
Oncology
Gastroenterology
Related publications
Targeted Approach to Metastatic Colorectal Cancer: What Comes Beyond Epidermal Growth Factor Receptor Antibodies and Bevacizumab?
Therapeutic Advances in Medical Oncology
Oncology
Patterns of Use and Tolerance of Anti–Epidermal Growth Factor Receptor Antibodies in Older Adults With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Association Between Serum Ligands and the Skin Toxicity of Anti-Epidermal Growth Factor Receptor Antibody in Metastatic Colorectal Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?
Journal of Oncology
Oncology
Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer Patients in Asia: Results From a Large, Multicountry Study
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship With Clinicopathological Characteristics
Middle East Journal of Digestive Diseases
Hepatology
Gastroenterology
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Role of Epidermal Growth Factor Receptor in Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
